Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
4(17%)
Results Posted
20%(3 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
2
8%
Ph phase_2
3
13%
Ph phase_3
9
38%
Ph early_phase_1
1
4%
Ph not_applicable
5
21%
Ph phase_4
4
17%

Phase Distribution

3

Early Stage

3

Mid Stage

13

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
1(4.2%)
Phase 1Safety & dosage
2(8.3%)
Phase 2Efficacy & side effects
3(12.5%)
Phase 3Large-scale testing
9(37.5%)
Phase 4Post-market surveillance
4(16.7%)
N/ANon-phased studies
5(20.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

4

trials recruiting

Total Trials

24

all time

Status Distribution
Active(4)
Completed(15)
Terminated(2)
Other(3)

Detailed Status

Completed15
Recruiting4
unknown3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
4
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.2%)
Phase 12 (8.3%)
Phase 23 (12.5%)
Phase 39 (37.5%)
Phase 44 (16.7%)
N/A5 (20.8%)

Trials by Status

terminated14%
unknown313%
recruiting417%
completed1563%
withdrawn14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT06312813Phase 2

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Recruiting
NCT06778434Phase 2

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Recruiting
NCT06497647Not Applicable

New Treatment for Nocturnal Enuresis in Children

Recruiting
NCT05688904Phase 1

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Recruiting
NCT03122444Early Phase 1

Imipramine on ER+ve and Triple Negative Breast Cancer

Completed
NCT05677295Phase 3

Therapeutic Efficacy in Women With Stress Urinary Incontinence

Unknown
NCT04412876Phase 3

Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study

Withdrawn
NCT00296725Phase 1

Dichotic Listening as a Predictor of Medication Response in Depression

Completed
NCT00404755Phase 4

Dichotic Listening as a Predictor of Medication Response in Depression

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated
NCT00164775Phase 3

The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia

Completed
NCT01179828Phase 3

Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio)

Completed
NCT00000518Phase 3

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Completed
NCT01753128Phase 3

Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn

Completed
NCT00000464Phase 3

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)

Completed
NCT01896349Not Applicable

Interpersonal Psychotherapy for Treatment Resistant Depression

Unknown
NCT00227955Phase 4

Comparing Various Treatments for Achieving and Maintaining Remission of Depression

Completed
NCT00004834Not Applicable

Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder

Completed
NCT01028014Not Applicable

Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters

Completed
NCT00296777Phase 4

Treatment of Depression Following Multiple Brain Tests

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24